Journal article

Killer cell immunoglobulin-like receptor 3DL1 polymorphism defines distinct hierarchies of HLA class I recognition

Philippa M Saunders, Phillip Pymm, Gabriella Pietra, Victoria A Hughes, Corinne Hitchen, Geraldine M O'Connor, Fabrizio Loiacono, Jacqueline Widjaja, David A Price, Michela Falco, Maria Cristina Mingari, Lorenzo Moretta, Daniel W McVicar, Jamie Rossjohn, Andrew G Brooks, Julian P Vivian

Journal of Experimental Medicine | ROCKEFELLER UNIV PRESS | Published : 2016

Grants

Awarded by National Health and Medical Research Council (NHMRC)


Awarded by Worldwide Cancer Research organization


Awarded by National Cancer Institute


Awarded by Associazione Italiana per la Ricerca sul Cancro


Awarded by Wellcome Trust


Awarded by NHMRC


Awarded by Australian Research Council DECRA Fellowship


Awarded by Worldwide Cancer Research


Awarded by NATIONAL CANCER INSTITUTE


Funding Acknowledgements

This work was funded by grants from the National Health and Medical Research Council (NHMRC; 1016629, 1046685, 1062267) and the Worldwide Cancer Research organization (12-1076). This work was funded in part by the National Cancer Institute (ZIA BC010747) and the National Institutes of Health Intramural AIDS Targeted Antiviral Program. L. Moretta is supported by the Associazione Italiana per la Ricerca sul Cancro (9962). D.A. Price is supported by a Wellcome Trust Senior Investigator Award (100326/Z/12/Z). J. Rossjohn is supported by an Australia Fellowship from the NHMRC (AF50). J.P. Vivian is supported by an Australian Research Council DECRA Fellowship (130101504).